Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4302 Pst2774 Oxalate
Na-K ATPase inhibitor, stimulating SERCA2a and accelerating calcium cycling in heart failure by relieving phospholamban inhibition
More description
DCC4301 Psma-sulfocy7
Novel PSMA ligand conjugated with fluorescent dye SulfoCy7, demonstrating good visualization of PSMA-expressing tumors and the absence of any explicit toxicity up to 87.9 mg/kg
More description
DCC4300 Psma-1092
Novel Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection, Visualizing Tumors in Real Time
More description
DCC4299 psb-sb-489
Novel Selective, competitive GPR55 antagonist
More description
DCC4298 psb-sb-1203
Potent GPR55 antagonist
More description
DCC4297 Psb-kd477
Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55
More description
DCC4296 Psb-kd107
Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55
More description
DCC4295 Psb-6426
The first potent and selective inhibitor of human nucleoside triphosphate diphosphohydrolase-2 (NTPDase2)
More description
DCC4294 Psb-19416
Fluorescent Probe for Ecto-5'--nucleotidase (CD73)
More description
DCC4293 Psb-18484
Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 32.1 nM)
More description
DCC4291 Psb-18332
Fluorescent Probe for Ecto-5'--nucleotidase (CD73)
More description
DCC4290 Psb-16434
Novel potent and selective agonist of the orphan G protein-coupled receptor 84 (GPR84)
More description
DCC4289 Psb-16282
Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 12 nM)
More description
DCC4288 Psb-16133
Novel Potent and Selective Antagonist for the UTP-Activated P2Y4 Receptor
More description
DCC4287 Psb-16131
Novel potent Lp1NTPDase inhibitor
More description
DCC4284 Psb-1410
Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B)
More description
DCC4283 Psb-12105
Novel fluorescent-labeled selective adenosine A2B receptor antagonist
More description
DCC4282 Psb-10211
Potent competitive antagonist and positive modulator of the P2X2 receptor
More description
DCC4281 Psb-10129
Positive modulator of ATP effects at P2X2 receptors
More description
DCC4280 Psb-1011
Potent competitive antagonist and positive modulator of the P2X2 receptor with >100-fold selectivity versus P2X4, P2X7, and several investigated P2Y receptor subtypes (P2Y(2,4,6,12))
More description
DCC4279 Psammaplysin F
Unique inhibitor of bacterial chromosomal partitioning, increasing the efficacy of bortezomib and sorafenib through regulation of stress granule formation
More description
DCC4278 Psammaplysene B
Naturally occurring inhibitor of FOXO1a nuclear export
More description
DCC4277 Ps121912
Highly potent and selective VDR-coactivator inhibitor
More description
DCC4276 Ps1145 Dihydrochloride
Novel inhibitor of upstream IκB kinase (IKK), specifically inhibiting the IκB phosphorylation and degradation and the subsequent nuclear translocation of NF-κB
More description
DCC4274 Prx-07034
Novel selective 5-HT6 receptor antagonist, enhancing cognition and memory and potently decreasing food intake and body weight in rodents
More description
DCC4273 Prucalopride Hydrochloride
Selective 5-HT4 agonist
More description
DCC4272 Pr-snf
Novel potent and selective inhibitor of SETD2
More description
DCC4271 Prs-211375
Novel selective CB2 agonist (CB2: 17.4 nM and CB1: 5585 nM)
More description
DCC4270 Protegenin A
Novel bacterial polyyne contributing to the antioomycete and plant-protective effects of P. protegens
More description
DCC4269 Protac-i
Novel PROTAC, targeting steroid hormone receptors for ubiquitination and degradation
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X